-
Laminar Pharma Announces “Last Patient, Last Visit” in LAM561 Phase 2b/3 Trial for Newly Diagnosed Glioblastoma Patients
PALMA DE MALLORCA, Spain, July 24, 2026 /PRNewswire/ — Laminar Pharma, a leader in the development of innovative therapies based on a novel membrane lipid therapy approach, today announced that the last patient has completed their last visit (LPLV) in the company’s Phase 2b/3 clinical trial of its lead asset, LAM561, in patients with newly diagnosed…
-
SUNRATE Highlights Enhanced Strategic Collaboration with Sabre to Deliver End-to-End Payment Capabilities for the Travel Industry
BARCELONA, Spain, June 15, 2026 /PRNewswire/ — SUNRATE, the global payment and treasury management platform, today announced at Phocuswright Europe its enhanced collaboration with Sabre, an AI‑native technology leader powering travel retailing at global scale, to deliver more comprehensive and seamless global payment capabilities for travel businesses worldwide. Building on a broader payments ecosystem, SUNRATE…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.
